- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02601144
Variable Frequency Stimulation of Subthalamic Nucleus for Freezing of Gait in Parkinson's Disease
March 18, 2017 updated by: Beijing Pins Medical Co., Ltd
Double-Blind Trial of Variable Frequency Stimulation for Freezing of Gait in Parkinson's Disease
This is the first study on the effect of the variable frequency stimulation (VFS) on Freezing of gait (FOG) in Parkinson's disease (PD) patients with STN DBS.
FOG has responded poorly to High frequency stimulation (HFS) but can be alleviated by relatively VFS.
This study would have significant clinical implications in the management of Freezing of gait (FOG) in these PD patients with subthalamic nucleus (STN) DBS.
The investigators hypothesize that VFS could have better effect on FOG than HFS and low frequency stimulation (LFS).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
HFS of STN provides consistent, long-term improvement of the cardinal motor signs of PD, such as bradykinesia, tremor and rigidity.
FOG has responded poorly to HFS and tends to continue to deteriorate over time, but this can be alleviated by relatively LFS.
Evidence has indicated that LFS-STN can improve axial signs in some but not all PD patients, but most of them experienced loss of efficacy in the short term.
Then comes to the little improvement or even worse of tremor, rigidity and bradykinesia, which consists of the three main symptoms of Parkinson's disease.
Thus even if axial problems could be solved by LFS in a long way, it could also be hard to tolerate by those patients.
The effect of VFS on FOG will be studied.
The investigators hypothesize that VFS could have better effect on Freezing of gait than HFS and LFS.
Study Type
Interventional
Enrollment (Actual)
28
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100040
- Tsinghua University Yuquan Hospital
-
Beijing, Beijing, China, 100050
- Beijing Tian Tan Hospital,Capital Medical University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients were receiving bilateral STN stimulation for more than six months.
- They were optimized on conventional HFS for control of tremors, rigidity and bradykinesia yet complained of freezing of gait.
- Subjects had an ability to walk at least 10 meters independently during ON DBS condition.
Exclusion criteria:
- gait disorders perceived by patients as a direct consequence of STN stimulation and not the primary disease.
- any change in the HFS DBS settings, three months prior to participation in the study.
- complete inability to walk despite assistance while DBS ON.
- Subjects responding to reprogramming of chronic DBS settings (report improvement of freezing).
- Subjects could not tolerate prolonged OFF medication condition.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NON_RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: VFS
variable frequency deep brain stimulation (VFS)
|
Deep Brain Stimulation
|
|
ACTIVE_COMPARATOR: HFS
high frequency deep brain stimulation (HFS)
|
Deep Brain Stimulation
|
|
ACTIVE_COMPARATOR: LFS
low frequency deep brain stimulation (LFS)
|
Deep Brain Stimulation
|
|
NO_INTERVENTION: DBS off
deep brain stimulation off
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Timed Up and Go (TUG) task
Time Frame: The outcome of TUG task at 12 months follow-up.
|
variable frequency stimulation (VFS) setting compared to high frequency stimulation (HFS) and low frequency stimulation (LFS)
|
The outcome of TUG task at 12 months follow-up.
|
|
the number of freezing episodes for TUG task
Time Frame: The outcome of TUG task at 12 months follow-up.
|
variable frequency stimulation (VFS) setting compared to high frequency stimulation (HFS) and low frequency stimulation (LFS)
|
The outcome of TUG task at 12 months follow-up.
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
UPDRS III scores
Time Frame: Outcome of VFS at 6、12 months with reference to baseline HFS
|
Outcome of VFS at 6、12 months with reference to baseline HFS
|
|
Gait and Falls Questionnaire (GFQ) scores
Time Frame: Outcome of VFS at 6、12 months with reference to baseline HFS
|
Outcome of VFS at 6、12 months with reference to baseline HFS
|
|
the39-item Parkinson's Disease Questionnaire (PDQ-39) scores
Time Frame: Outcome of VFS at 6、12 months with reference to baseline HFS
|
Outcome of VFS at 6、12 months with reference to baseline HFS
|
|
the Freezing of Gait Questionnaire (FOG-Q) scores
Time Frame: Outcome of VFS at 6 、12months with reference to baseline HFS
|
Outcome of VFS at 6 、12months with reference to baseline HFS
|
|
Number of adverse events (AE's)
Time Frame: Change from Baseline to 6、12 Months
|
Change from Baseline to 6、12 Months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Luming Li, Ph.D, Tsinghua University
- Study Chair: Michael Okun, MD., University of Florida
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2015
Primary Completion (ACTUAL)
December 1, 2016
Study Completion (ACTUAL)
December 1, 2016
Study Registration Dates
First Submitted
October 12, 2015
First Submitted That Met QC Criteria
November 8, 2015
First Posted (ESTIMATE)
November 10, 2015
Study Record Updates
Last Update Posted (ACTUAL)
March 21, 2017
Last Update Submitted That Met QC Criteria
March 18, 2017
Last Verified
March 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PINS-014
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson's Disease
-
EicOsis Human Health Inc.University of California, Davis; Michael J. Fox Foundation for Parkinson's...RecruitingParkinson's Disease (PD)United States
-
University of Kansas Medical CenterNot yet recruitingParkinson's Disease (PD)United States
-
AbbVieRecruiting
-
University Hospital Schleswig-HolsteinUniversity of Kiel; University of Cologne; University Hospital, Bonn; Philipps...Not yet recruitingParkinson's Disease (PD)
-
InvicroMerck Sharp & Dohme LLCRecruitingParkinson's Disease | Parkinson's Disease (PD) | Parkinson's Disease (Disorder)United States
-
Ohio State UniversityCompletedParkinson's Disease | Parkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease | Parkinson Disease, Idiopathic | Parkinson's Disease, IdiopathicUnited States
-
Assistance Publique - Hôpitaux de ParisFrance Parkinson AssociationUnknownHealthy Controls | Parkinson's Disease With LRRK2 Mutation | Parkinson's Disease Without LRRK2 MutationFrance
-
Guangzhou Henovcom Bioscience Co. Ltd.Frontage Clinical Services, Inc.Active, not recruitingParkinson's Disease (PD)United States
-
Universitätsklinikum Hamburg-EppendorfUniversity of TwenteRecruitingParkinson's Disease | Deep Brain StimulationGermany
-
Mission TherapeuticsMichael J. Fox Foundation for Parkinson's Research; Parkinson's UKRecruitingParkinson's Disease (PD) | Early Stage Parkinson's Disease | Mild to Moderate Parkinson's DiseaseUnited Kingdom
Clinical Trials on Deep Brain Stimulation
-
University of FloridaBoston Scientific CorporationRecruitingParkinson Disease | Deep Brain StimulationUnited States
-
Abbott Medical DevicesTerminatedDepressive Disorder, Major | Unipolar DepressionUnited States, Canada, United Kingdom
-
Ali Rezai, MDCompleted
-
Zhiqi MaoRecruitingParkinson's Disease | Executive Function | Electroencephalogram | Functional Near - Infrared SpectroscopyChina
-
University of CambridgeKing's College Hospital NHS Trust; Cambridge University Hospitals NHS Foundation...RecruitingAlcohol Use DisorderUnited Kingdom
-
University Hospital Inselspital, BerneCompletedMovement Disorder | Urinary Tract DiseaseSwitzerland
-
NewronikaTerminatedParkinson DiseaseItaly
-
University of California, San FranciscoNational Institute of Neurological Disorders and Stroke (NINDS)RecruitingPD - Parkinson's DiseaseUnited States
-
University of MinnesotaRecruitingParkinson DiseaseUnited States
-
Nova Scotia Health AuthorityNot yet recruitingParkinson DiseaseCanada